Component,Publication Grant Number,Publication Doi,Publication Journal,Pubmed Id,Pubmed Url,Publication Title,Publication Year,Publication Keywords,Publication Authors,Publication Abstract,Publication Assay,Publication Tumor Type,Publication Tissue,Publication Dataset Alias,Publication Accessibility,PublicationView_id
PublicationView,CA217377,10.1038/s41586-023-05940-w,Nature,37076617,https://pubmed.ncbi.nlm.nih.gov/37076617,PI3Kβ controls immune evasion in PTEN-deficient breast tumours,2023,,"Johann S Bergholz, Qiwei Wang, Qi Wang, Michelle Ramseier, Sanjay Prakadan, Weihua Wang, Rong Fang, Sheheryar Kabraji, Qian Zhou, G Kenneth Gray, Kayley Abell-Hart, Shaozhen Xie, Xiaocan Guo, Hao Gu, Thanh Von, Tao Jiang, Shuang Tang, Gordon J Freeman, Hye-Jung Kim, Alex K Shalek, Thomas M Roberts, Jean J Zhao","Loss of the PTEN tumour suppressor is one of the most common oncogenic drivers across all cancer types<sup>1</sup>. PTEN is the major negative regulator of PI3K signalling. The PI3Kβ isoform has been shown to play an important role in PTEN-deficient tumours, but the mechanisms underlying the importance of PI3Kβ activity remain elusive. Here, using a syngeneic genetically engineered mouse model of (Read more on Pubmed)",Pending Annotation,Pending Annotation,Pending Annotation,"SRX19333312, SRX19333246, SRX19333238, SRX19333274, SRX19333276, SRP421642, SRX19333287, SRX19333298, SRX19333277, SRX19333245, SRX19333322, SRX19333289, SRX19333317, SRX19333290, GSE225064, SRX19320393, SRX19333275, SRX19333252, SRX19320391, SRX19333321, SRX19320392, SRX19333331, SRX19333330, SRX19320397, SRX19333253, SRX19333291, SRX19333278, SRX19333259, SRX19333311, SRX19333244, SRX19333248, S(Read more on Pubmed)",Restricted Access,37076617
